Drug Shortage Report for TREANDA

Last updated on 2025-05-02 History

Report ID	244075
Drug Identification Number	02392569
Brand name	TREANDA
Common or Proper name	TREANDA 100MG/20ML FOR INJECTION
Company Name	TEVA CANADA LIMITED
Market Status	MARKETED
Active Ingredient(s)	BENDAMUSTINE HYDROCHLORIDE
Strength(s)	100MG
Dosage form(s)	POWDER FOR SOLUTION
Route of administration	INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN) Click here to see a list of all reports for this drug.	(See additional packaging sizes)
Additional packaging sizes	20ML
ATC code	L01AA
ATC description	ALKYLATINGAGENTS
Reason for shortage	Disruption of the manufacture of the drug.
Anticipated start date
Actual start date	2024-11-27
Estimated end date	2025-05-20
Actual end date	2025-05-01
Shortage status	Resolved
Updated date	2025-05-02
Company comments
Health Canada comments
Tier 3 Status	No
Contact Address	30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Showing 1 to 20 of 23